Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$34.5 - $42.19 $4,312 - $5,273
-125 Reduced 2.09%
5,859 $246,000
Q1 2023

May 15, 2023

BUY
$33.32 - $40.98 $199,386 - $245,224
5,984 New
5,984 $213,000
Q1 2021

May 17, 2021

SELL
$67.36 - $80.76 $554,170 - $664,412
-8,227 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$53.08 - $69.86 $1.45 Million - $1.91 Million
-27,379 Reduced 76.89%
8,227 $561,000
Q3 2020

Nov 16, 2020

BUY
$51.29 - $65.09 $1.83 Million - $2.32 Million
35,606 New
35,606 $1.89 Million
Q2 2019

Aug 14, 2019

SELL
$40.81 - $52.42 $450,501 - $578,664
-11,039 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$36.91 - $55.7 $407,449 - $614,872
11,039 New
11,039 $571,000
Q4 2018

Feb 14, 2019

SELL
$36.49 - $51.72 $346,873 - $491,650
-9,506 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$46.5 - $53.55 $442,029 - $509,046
9,506 New
9,506 $490,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.